Aurobindo Pharma is reportedly planning to ramp up its generic business in the western European markets. While, the company has acquired about 1,250 dossiers as part of its strategy to expand in the region, it is likely to launch some more new products in the current financial year.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin - Google+
For more information ✆ – 0731-6642300 or Visit http://ift.tt/1k8NnLH
04:08
Unknown
Posted in:
0 comments:
Post a Comment